Total submissions: 15
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000123793 | SCV000167136 | benign | not specified | 2014-03-18 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Invitae | RCV000226243 | SCV000288642 | benign | Oligodontia-cancer predisposition syndrome | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000226243 | SCV000405711 | benign | Oligodontia-cancer predisposition syndrome | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Ce |
RCV000858430 | SCV001151406 | likely benign | not provided | 2024-02-01 | criteria provided, single submitter | clinical testing | AXIN2: BP4, BP7 |
Ambry Genetics | RCV001017309 | SCV001178375 | likely benign | Hereditary cancer-predisposing syndrome | 2018-11-29 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000123793 | SCV001362149 | benign | not specified | 2019-02-25 | criteria provided, single submitter | clinical testing | Variant summary: The variant, AXIN2 c.1101C>T alters a non-conserved nucleotide resulting in a synonymous change. 5/5 computational tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 0.00078 in 276804 control chromosomes. The observed variant frequency is approximately 5 fold of the estimated maximal expected allele frequency for a pathogenic variant in AXIN2 causing Colorectal Cancer phenotype (0.00014), strongly suggesting that the variant is benign. To our knowledge, no occurrence of c.1101C>T in individuals affected with Colorectal Cancer and no experimental evidence demonstrating its impact on protein function have been reported. Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and classified the variant as benign or likely benign. Based on the evidence outlined above, the variant was classified as benign. |
Quest Diagnostics Nichols Institute San Juan Capistrano | RCV000858430 | SCV002046812 | benign | not provided | 2021-04-02 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV001017309 | SCV002537569 | benign | Hereditary cancer-predisposing syndrome | 2020-11-25 | criteria provided, single submitter | curation | |
Center for Genomic Medicine, |
RCV000123793 | SCV002551286 | uncertain significance | not specified | 2024-02-06 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV000226243 | SCV004016312 | benign | Oligodontia-cancer predisposition syndrome | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003925230 | SCV004740391 | benign | AXIN2-related condition | 2019-02-19 | criteria provided, single submitter | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Genome Diagnostics Laboratory, |
RCV000858430 | SCV001808501 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000858430 | SCV001918862 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000858430 | SCV001972923 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV000858430 | SCV002036223 | likely benign | not provided | no assertion criteria provided | clinical testing |